191 related articles for article (PubMed ID: 19700350)
1. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials.
Landoni G; Mizzi A; Biondi-Zoccai G; Bruno G; Bignami E; Corno L; Zambon M; Gerli C; Zangrillo A
J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):51-7. PubMed ID: 19700350
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan does not reduce mortality in cardiac surgery.
Takagi H; Umemoto T
J Cardiothorac Vasc Anesth; 2011 Jun; 25(3):579; author reply 579-80. PubMed ID: 20728375
[No Abstract] [Full Text] [Related]
3. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
[TBL] [Abstract][Full Text] [Related]
4. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies.
Zangrillo A; Biondi-Zoccai G; Mizzi A; Bruno G; Bignami E; Gerli C; De Santis V; Tritapepe L; Landoni G
J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):474-8. PubMed ID: 19217315
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial.
Husedzinović I; Barisin S; Bradić N; Barisin A; Sonicki Z; Milanović R
Croat Med J; 2005 Dec; 46(6):950-6. PubMed ID: 16342349
[TBL] [Abstract][Full Text] [Related]
6. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
7. Levosimendan reduces mortality in critically ill patients. A meta-analysis of randomized controlled studies.
Landoni G; Mizzi A; Biondi-Zoccai G; Bignami E; Prati P; Ajello V; Marino G; Guarracino F; Zangrillo A
Minerva Anestesiol; 2010 Apr; 76(4):276-86. PubMed ID: 20332741
[TBL] [Abstract][Full Text] [Related]
8. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R
Int J Cardiol; 2010 Feb; 138(3):281-9. PubMed ID: 18817994
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trials with levosimendan.
Mebazaa A; Barraud D; Welschbillig S
Am J Cardiol; 2005 Sep; 96(6A):74G-9G. PubMed ID: 16181826
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan meta-analyses: Is there a pattern in the effect on mortality?
Pollesello P; Parissis J; Kivikko M; Harjola VP
Int J Cardiol; 2016 Apr; 209():77-83. PubMed ID: 26882190
[TBL] [Abstract][Full Text] [Related]
11. Successful use of levosimendan in a patient during cardiopulmonary bypass.
Iriz E; Erer D; Unal Y; Zor H; Ozkose Z; Ozdogan ME
J Card Surg; 2007; 22(2):153-6. PubMed ID: 17338755
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan: a new option in acute cardiac failure.
Holley AD; Ziegenfuss M
Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641
[No Abstract] [Full Text] [Related]
14. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
Elahi MM; Lam J; Asopa S; Matata BM
J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
[No Abstract] [Full Text] [Related]
15. Does off-pump or minimally invasive coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with percutaneous coronary intervention? A meta-analysis of randomized trials.
Bainbridge D; Cheng D; Martin J; Novick R;
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):623-31. PubMed ID: 17320555
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute heart failure in an infant after cardiac surgery using levosimendan.
Braun JP; Schneider M; Kastrup M; Liu J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):228-30. PubMed ID: 15201012
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
Lim JY; Deo SV; Rababa'h A; Altarabsheh SE; Cho YH; Hang D; McGraw M; Avery EG; Markowitz AH; Park SJ
J Card Surg; 2015 Jul; 30(7):547-54. PubMed ID: 25989324
[TBL] [Abstract][Full Text] [Related]
19. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
Niu ZZ; Wu SM; Sun WY; Hou WM; Chi YF
J Cardiovasc Pharmacol; 2014 Feb; 63(2):107-12. PubMed ID: 24126568
[TBL] [Abstract][Full Text] [Related]
20. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
Grieshaber P; Lipp S; Arnold A; Görlach G; Wollbrück M; Roth P; Niemann B; Wilhelm J; Böning A
J Cardiothorac Surg; 2016 Dec; 11(1):162. PubMed ID: 27906091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
